Analyst Peter Lawson works at BARCLAYS and is focused on the Healthcare sector with 311 price targets and ratings documented since 2012 spanning on 29 stocks. Previously, Peter Lawson worked at TRUIST, MIZUHO. Analyst's average stock valuation to be materialised ratio is 61.52% with an average time for price targets to be met of 156.48 days.
Most recent stock forecast was given on ARVN, Arvinas, Inc at 23-Nov-2022.
Peter Lawson best performing recommendations are on MGNX (MACROGENICS, INC).
The best stock recommendation documented was for MGNX (MACROGENICS, INC) at 3/4/2020. The price target of $8 was fulfilled within 1 day with a profit of $0.5 (5.88%) receiving and performance score of 58.82.
Average potential price target upside